APHのチャート
APHの企業情報
| symbol | APH |
|---|---|
| 会社名 | Amphenol Corp. （APH アンフェノ―ル） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 電子機器装置_部品 工業（Industrials） |
| 概要 | 事業概要 アンフェノール(Amphenol Corporation)は電気・電子・光ファイバーコネクタ、相互接続システム、アンテナ、センサおよびセンサベース製品、同軸・専用ケーブルを設計・製造・販売する企業である。同社は2つの事業を運営する。相互接続製品と組立事業はエンド・マーケットのアプリケーションで使用されるコネクタおよびコネクタ・システム、付加価値製品、およびアンテナ、センサーを含む製品の設計、製造および販売に従事する。ケーブル製品とソリューション事業は、主にブロードバンド通信と情報技術市場で使用するケーブル、付加価値製品、コンポーネントの設計、製造およびマーケティングに従事する。同社は アメリカ、ヨーロッパ、アジア、オーストラリア、アフリカにある各施設で製品の設計、製造、組立を行う。 アンフェノ―ルは電気、電子、光ファイバ―・コネクタの世界大手メ―カ―。相互接続システム、アンテナ、センサ―、高速特殊ケ―ブルの製造に従事。同社は2つの事業から構成。インタ―コネクト製品部門はコネクタ・システム、アンテナ、センサ―などを含み、ケ―ブル製品とソリュ―ション部門はブロ―ドバンド通信市場に製品を提供する。 |
| 本社所在地 | 358 Hall Avenue Wallingford CT 06492 USA |
| 代表者氏名 | Martin H. Loeffler |
| 代表者役職名 | Independent Chairman of the board |
| 電話番号 | +1 203-265-8900 |
| 設立年月日 | 1986年 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 73600人 |
| url | www.amphenol.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 1995.10000 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 28151.36000 |
| 売上高 | 売上高（百万ドル） 8202.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 30430.36000 |
| 当期純利益 | 当期純利益（百万ドル） 1292.10000 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Amphenol Corporation revenues increased 17% to $8.2B. Net income before extraordinary items increased 23% to $1.29B. Revenues reflect Interconnect Products segment increase of 18% to $7.78B Cable Products segment increase of 4% to $420.1M China segment increase of 25% to $2.59B United States segment increase of 13% to $2.24B. |
APHのテクニカル分析
APHのニュース
Is Aphria (TSX:APHA) Stock a Buy After its Potential Merger With Tilray (NASDAQ:TLRY)? 2021/01/08 17:00:55 The Motley Fool Canada
Aphria's merger with Tilray will result in one of the largest cannabis companies in the world. The post Is Aphria (TSX:APHA) Stock a Buy After its Potential Merger With Tilray (NASDAQ:TLRY)? appeared first on The Motley Fool Canada .
Cannabis Vets From Poseidon, Curaleaf, Aphria And TILT Share Projections For 2021 2021/01/08 15:41:00 Benzinga
The past twelve months were pivotal for the cannabis industry, as 2020 welcomed a myriad of triumphs, including: Essential business status during the COVID-19 pandemic Four U.S. states voting yes to recreational marijuana The U.S. House of Representatives' approving Marijuana Opportunity Reinvestment and Expungement (MORE) Act, a bill constructed to remove marijuana from the list of federally controlled substances The passing of a bill to reduce barriers and advance scientific research into medical cannabis. An increase in cannabis sales and record levels of tax revenue A European court ruling against restrictions on CBD commerce And an uptick in celebrity backing So, what will 2021 bring? Benzinga reached out to a number of cannabis industry veterans to learn more. 2020 Was A Proving Ground "From an industry perspective, we saw necessary culling of the poor operators and the acceleration of sustainable growth for the leading MSOs and ancillary companies in the U.S.," Emily Paxhia , managing director and co-founder of Poseidon Asset Management , said.
Pot stocks high as Democrats on brink of controlling U.S. Senate 2021/01/06 15:15:58 Yahoo Finance
U.S.-listed shares of Aphria Inc,, Hexo Corp and Cronos Group rose between 10.4% and 13%. Pot stocks have rallied since Joe Biden's victory in the U.S. presidential elections in November and higher demand for pot during the coronavirus-led lockdowns. Vice President-elect Kamal Harris' has promised pot decriminalization, which would remove it from the classified substances list.
Aphria Inc. to Announce Second Quarter Fiscal 2021 Financial Results on January 14, 2021 2021/01/06 13:00:00 Cision (Canada)
/CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA) (Nasdaq: APHA), a leading global cannabis company inspiring and empowering the worldwide community…
Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients 2021/01/04 14:15:00 PR Newswire
/PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for…
'Psyched': Havn Life Goes Public, CannaGlobal Inks Merger, Numinus Raises CA$4.6M 2020/09/11 21:01:18 Benzinga
Havn Life Goes Public on CSE and Announces Authorization for Research Havn Life Sciences Inc . (CSE : HAVN ), a recently-formed psychedelics company, announced on Tuesday its debut on the Canadian Securities Exchange under the symbol HAVN. The company is led by co-CEOs Susan Chapelle and Tim Moore, the former CEO of cannabis company Green Growth Brands Inc. Other supporters include Vic Neufeld , former CEO of Aphria (NASDAQ: APHA ), who serves as director of the board. The board also includes Canada’s former deputy prime minister Sheila Copps. Formed in June of 2020, Havn defines itself as a biotechnology company focused on “unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi.” The company operates a research facility located in the South Campus at The University of British Columbia. “We are currently working on … Full story available on Benzinga.com
VIDEO — Ex-Aphria Boss Vic Neufeld Joins Psychedelics Industry 2020/09/10 23:30:26 Investing News Network
Vic Neufeld, ex-CEO of Canadian cannabis producer Aphria, is back — and this time he's joining the rising psychedelics industry. The post VIDEO — Ex-Aphria Boss Vic Neufeld Joins Psychedelics Industry appeared first on Investing News Network .
Research Report: Bio-MEMS Devices Market (2020-2024) | Growing Geriatric Population to Boost Market Growth | Technavio 2020/09/09 06:45:00 Benzinga
Technavio has been monitoring the bio-MEMS devices market and it is poised to grow by USD 11.92 billion during 2020-2024, progressing at a CAGR of almost 24% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200908005942/en/ Technavio has announced its latest market research report titled Global Bio-MEMS Devices Market 2020-2024 (Graphic: Business Wire) Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
1 Weed Stock IPO on the TSX Is a Low-Key Millionaire Maker 2020/09/08 17:00:03 The Motley Fool Canada
Here's why Aphria (TSX:APHA)(NASDAQ:APHA) stock has strong long-term prospects given its huge market presence and low valuation multiple. The post 1 Weed Stock IPO on the TSX Is a Low-Key Millionaire Maker appeared first on The Motley Fool Canada .
Amphenol Loses Momentum while Nvidia Continues to Flourish 2020/09/03 22:34:44 ValueWalk
Stocks staged a very strong advance relative to bonds in the month of August. The broad market index was up 7.2% and the long treasury bond index was down 6%. That rally in the face of a steep decline in corporate growth is creating opportunities. Most of the advance was accounted for by a further […] The post Amphenol Loses Momentum while Nvidia Continues to Flourish appeared first on ValueWalk .